AU6331696A - Fused soluble mhc heterodimer:peptide complexes and their uses - Google Patents

Fused soluble mhc heterodimer:peptide complexes and their uses

Info

Publication number
AU6331696A
AU6331696A AU63316/96A AU6331696A AU6331696A AU 6331696 A AU6331696 A AU 6331696A AU 63316/96 A AU63316/96 A AU 63316/96A AU 6331696 A AU6331696 A AU 6331696A AU 6331696 A AU6331696 A AU 6331696A
Authority
AU
Australia
Prior art keywords
peptide complexes
soluble mhc
mhc heterodimer
fused soluble
fused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63316/96A
Inventor
Shrinkant Deshpande
Jane A. Gross
Wayne Kindsvogel
Eva Pia Reich
Paul O Sheppard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Anergen Inc
Original Assignee
Zymogenetics Inc
Anergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc, Anergen Inc filed Critical Zymogenetics Inc
Publication of AU6331696A publication Critical patent/AU6331696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU63316/96A 1995-06-07 1996-06-07 Fused soluble mhc heterodimer:peptide complexes and their uses Abandoned AU6331696A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US48000295A 1995-06-07 1995-06-07
US48213395A 1995-06-07 1995-06-07
US48324195A 1995-06-07 1995-06-07
US482133 1995-06-07
US483241 1995-06-07
US480002 1995-06-07
US596495P 1995-10-27 1995-10-27
US005964 1995-10-27
PCT/US1996/010102 WO1996040944A2 (en) 1995-06-07 1996-06-07 Fused soluble mhc heterodimer:peptide complexes and their uses

Publications (1)

Publication Number Publication Date
AU6331696A true AU6331696A (en) 1996-12-30

Family

ID=27485544

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63316/96A Abandoned AU6331696A (en) 1995-06-07 1996-06-07 Fused soluble mhc heterodimer:peptide complexes and their uses

Country Status (6)

Country Link
EP (1) EP0833930A2 (en)
JP (1) JPH11507238A (en)
KR (1) KR19990022641A (en)
AU (1) AU6331696A (en)
CA (1) CA2224205A1 (en)
WO (1) WO1996040944A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10503379A (en) * 1994-07-29 1998-03-31 デイド・インターナショナル・インコーポレーテッド MHC complex and use thereof
US7074904B2 (en) 1994-07-29 2006-07-11 Altor Bioscience Corporation MHC complexes and uses thereof
US5869270A (en) * 1996-01-31 1999-02-09 Sunol Molecular Corporation Single chain MHC complexes and uses thereof
JP2002513558A (en) * 1998-05-05 2002-05-14 コリクサ コーポレイション Myelin basic protein peptide and use thereof
FR2778669B1 (en) * 1998-05-14 2002-06-14 Centre Nat Rech Scient PROCESS FOR EXPRESSING A COMPLEX FORMED OF AT LEAST ONE PRODUCT OF THE MAJOR HISTOCOMPATIBILITY COMPLEX AND A PEPTIDE IN A PHAGE, PHAGES AND COMPLEXES OBTAINED THEREFROM AND THEIR APPLICATIONS
CA2537759C (en) 2003-09-05 2015-03-24 Oregon Health & Science University Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells
CA2629881C (en) * 2005-11-17 2017-09-12 Rikard Holmdahl A compound comprising an autoantigenic peptide and a carrier with a mhc binding motif
US8491913B2 (en) 2009-03-07 2013-07-23 Oregon Health & Science University Compositions and methods using recombinant MHC molecules for the treatment of stroke
US9260506B2 (en) 2011-04-07 2016-02-16 Oregon Health & Science University Treatment of retinal disorders with recombinant T cell receptor ligand (RTL)
EP3052526A4 (en) 2013-10-03 2017-04-19 Oregon Health & Science University Recombinant polypeptides comprising mhc class ii 1 domains

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260422A (en) * 1988-06-23 1993-11-09 Anergen, Inc. MHC conjugates useful in ameliorating autoimmunity
GB9307371D0 (en) * 1993-04-08 1993-06-02 Walls Alan J Fusion proteins
WO1994025054A1 (en) * 1993-04-29 1994-11-10 Andrew Atkin Recombinant vaccine
US5820866A (en) * 1994-03-04 1998-10-13 National Jewish Center For Immunology And Respiratory Medicine Product and process for T cell regulation

Also Published As

Publication number Publication date
WO1996040944A3 (en) 1997-01-23
WO1996040944A2 (en) 1996-12-19
JPH11507238A (en) 1999-06-29
CA2224205A1 (en) 1996-12-19
EP0833930A2 (en) 1998-04-08
KR19990022641A (en) 1999-03-25

Similar Documents

Publication Publication Date Title
AU1363397A (en) Vision system and proximity detector
AU4397297A (en) Antibody against human parathormone related peptides
AU2527397A (en) Fas ligand fusion proteins and their uses
AU5159798A (en) Branched peptide linkers
AU5427196A (en) Materials collection system and uses thereof
AU4748497A (en) Three-dimensional imaging and display system
AU5952996A (en) Galvanometer and camera system
AU2597897A (en) Peptide ligands of the urokinase receptor
AU6331696A (en) Fused soluble mhc heterodimer:peptide complexes and their uses
AU4394396A (en) Modified peptides
AU7684896A (en) Fas ligand fusion protein
AU3804397A (en) Hexameric fusion proteins and uses therefor
AU4074997A (en) Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
AU2025395A (en) Sustained release preparations
AU4649293A (en) Angiotensin iv peptides and receptor
AU3305197A (en) Non-activated receptor complex proteins and uses thereof
AU4119397A (en) Novel combination preparations and their use in immunodiagnosis and immunotherapy
AU9040591A (en) Soluble mannose receptor peptides
ZA96240B (en) Novel peptides their preparation and use
AU5656596A (en) Allergen particle exclusion and/or retention covering
ZA96239B (en) Novel peptides their preparation and use
AU6890696A (en) Peptide derivatives
AU1142397A (en) Metal-regulated transporters and uses therefor
AU8030098A (en) Polypeptide presentation system
AU6890596A (en) Peptide derivatives